One hub for the whole bio-economy.
News, knowledge and practical tools across biotech, food-tech, agri-tech, probiotics, personalized medicine, bioprocessing and investment — with an AI assistant that helps you build.
Free to join · scientists, engineers, founders & investors welcome
Subscribe for the bio-economy, in your inbox
Get sector news, national biomanufacturing policies (GFI, BioE3, EU Biotech Act & more), and new bioprocess calculation tools — free, straight to your inbox.
Explore by sector
Each sector has its own colour, news and knowledge. Pick yours.
Therapeutics, genomics, synthetic biology and the science powering it all.
News & knowledge →Precision fermentation, alternative proteins and the future of food.
News & knowledge →Biologicals, crop science and sustainable agriculture.
News & knowledge →Microbiome, live cultures and functional health.
News & knowledge →Cell & gene therapy, diagnostics and precision care.
News & knowledge →Upstream, downstream, scale-up and biomanufacturing.
News & knowledge →Funding rounds, deals, M&A and the money moving the sector.
News & knowledge →Breakthroughs, publications and the frontier of discovery.
News & knowledge →National biomanufacturing strategies and public investment — GFI, India's BioE3, the US Bioeconomy initiative, the EU Biotech Act and more.
News & knowledge →Artificial intelligence and machine learning across the bio-economy — AI drug discovery, protein design, genomics, and smart bioprocessing.
News & knowledge →Market pulse — the sector, summarised
An AI-curated feed of the breakthroughs, funding rounds, approvals and deals moving biotech, food-tech, agri-tech and beyond — so you spend less time searching and more time building.
Everything the sector needs, in one place
Articles
Curated reading from the sector's best blogs and journals — biotech, bioprocessing, food-tech and agri-tech.
Open →🧮Bioprocess tools
Upstream & downstream calculators, scale-up, and AI-assisted URS document generators.
Open →📰Market news
Live headlines, deals and breakthroughs from across the entire life-sciences sector, updated daily.
Open →🤝Community
Connect with scientists, engineers, founders and investors solving the same problems.
Open →Latest articles
View all →
StockWatch: Gene Editing Shares Jump on ESGCT Data, FDA Draft Guidance
Shares of gene editing therapy companies mostly surged this past week on two growth catalysts: Data readouts at the European Society of Gene and Cell Therapy’s 33rd ESGCT Annual Congress, and the FDA's new draft guidance for personalized gene therapies.
By Alex Philippidis
How the NEXTY Awards open doors to valuable food service partnerships
Corporate food service providers offer bulk purchases, direct feedback and exposure to thousands of consumers. Here's how the NEXTY Awards can help you break in.
By Meredith Kaufman
Anthropic’s one-person biotech buy; Jake Van Naarden’s dealmaking strategy; and more
Hello and welcome back to a spooky Halloween edition of Endpoints Weekly! Sorry to all the candy corn lovers out there, but just noting that they’re actually made with bug secretions. The Atlantic has all ...
By Max GelmanJoin the people building the bio-economy
Create a free account to read every article, use the tools, follow your sectors, and grow with the community.
Create your free account